AQR Arbitrage’s Meridian Bioscience Inc VIVO Stock Holding History

AQR Arbitrage’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-806,832	Closed	-$26.8M	–	1260
2022 Q4	$26.8M	Buy	806,832 +192,712	+31%	+$6.21M	0.69%	25
2022 Q3	$19.4M	Buy	+614,120	New	+$19.9M	0.43%	48

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AQR Arbitrage's VIVO Position: Q1 2023 in Review

AQR Arbitrage sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 806,832 shares — an estimated $26.8M sold.

AQR Arbitrage first reported a position in VIVO in Q3 2022 and held it in 2 quarters. The position peaked at $26.8M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

AQR Arbitrage reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
AQR Arbitrage sold 806,832 Meridian Bioscience Inc shares in Q1 2023, an estimated $26.8M.
AQR Arbitrage first reported a position in Meridian Bioscience Inc in Q3 2022 and held it in 2 quarters.
AQR Arbitrage's Meridian Bioscience Inc position peaked at $26.8M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on AQR Arbitrage's 13F filing for Q1 2023, filed 15 May 2023.